U.S. Markets open in 13 hrs, 28 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 10,023.42 | 17.46 | 0.17% |
| NASDAQ | 2,112.44 | 7.12 | 0.34% |
| S&P 500 | 1,069.30 | 2.67 | 0.25% |
Experience real-time quotes &
news with the most powerful
iPhone application for investors.
Get the FREE DailyFinance iPhone application
| Day Low | 7.20 03:59 PM EST | |
|---|---|---|
| Day High | 7.6499 10:11 AM EST |
|
| Range | 0.45 |
| Volume | 49,602 | |
|---|---|---|
| 30-Day Avg Vol | 35,000 |
|
| Difference | 41.72% |
| Market Cap | 128.03 M | |
|---|---|---|
| Mkt Cap Chg | -6.51 M |
| Shares Out | 17.61 M | |
|---|---|---|
| % Shrs Traded | 0.28% | |
| 1yr EPS Est | -0.967 |
| 52-Wk Low | 0.89 | |
|---|---|---|
| 52-Wk High | 9.20 |
|
| Range | 8.31 |
| Prev Close | 7.64 11/5/09 | |
|---|---|---|
| Today's Open | 7.60 | |
| Change | -0.52% |
| Dividend (TTM) | 0.00 | |
|---|---|---|
| Div Yield (TTM) | 0.00% | |
| Ex-Div Date | — | |
| Div Date | — |
|
| Short Interest | 227,703.00 |
| Revenue (LFY) | 0 | |
|---|---|---|
| Earnings (LFY) | -26.04 M | |
| Earnings (MRQ) | -5.43 M | |
| Next Earn Est | -0.36 | |
| Next Earnings | 11/17/2009 |
|
| EPS (TTM) | -1.21 | |
| 1yr EPS Growth | 20.74% |
| P/E Ratio (TTM) | — | |
|---|---|---|
| P/E Ratio (Fwd) | -7.00 | |
| PEG Ratio | — | |
| Return on Equity | -84.75 | |
| Beta | — |
| Sector | Healthcare | |
|---|---|---|
| Industry | Drugs |
above for more info
NeurogesX is paving the way for treating neuropathic pain, or chronic pain caused by damaged nerves. The company's lead candidate is Qutenza (formerly known as NGX-4010), a skin patch that uses a synthetic ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| Next Quarter | -0.36 11/6/09 | — — |
—
—
|
| Last Quarter | -0.36 9/30/09 | -0.38 9/30/09 |
-0.02
Missed
|
| 2 Quarters Ago | -0.278 6/30/09 | -0.31 6/30/09 |
-0.032
Missed
|
| Quarterly - 06/30/2009 | Annual - 2008 | |
|---|---|---|
| Total Revenue | 0.00 | 0.00 |
| Gross Profit | — | -181,000.00 |
| Operating Income | -5.38 M | -26.29 M |
| Net Income | -5.43 M | -26.04 M |
Notices and Terms: Confirm all data with your broker before trading.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Quote data provided by Interactive Data. Real-Time prices provided by BATS. Historical prices provided by Prophet. Company Profile provided by Hoovers. Executive data and Industry/Sector information provided by Morningstar Inc. Earnings, Ownership, Financial Statement, Insider Trading, Conference Call schedules and SEC Filing information provided by Thomson Reuters.
Advanced Chart
Technical Charts